Health Canada accepted submissions from the Canadian company Apotex in January and from Switzerland-based Sandoz in November, according to the regulator’s website. Health Canada also accepted ...

The common diabetes drug metformin works partly by excreting sugar from the bloodstream into the intestines, where gut bacteria then convert it into chemicals that improve the insulin response.

use is associated with a reduced risk for developing hematologic cancers compared with insulin and metformin use, according to a ...

In May 2020, the Food and Drug Administration (FDA) recommended that some makers of metformin extended release remove some of their tablets from the U.S. market. This is because an unacceptable ...

Metformin. Metformin is an oral diabetes medication that helps keep your blood sugar in check by causing your liver to produce less glucose. It was approved by the FDA in 1994 for the treatment of ...

In their paper, titled “Metformin-regulated glucose flux from the circulation to the intestinal lumen,” the investigators concluded, “A previously unrecognized, substantial flux of glucose ...

AACHEN, Germany and TORONTO, Feb. 24, 2025 /PRNewswire/ -- Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based ...